Cargando…

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Congenital adrenal hyperplasia (CAH) was the fourth disorder added to the national Swedish neonatal screening program in 1986, and approximately 115,000 newborns are screened annually. Dried blood spot (DBS) screening with measurement of 17-hydroxyprogesterone (17OHP) is also offered to older childr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zetterström, Rolf H., Karlsson, Leif, Falhammar, Henrik, Lajic, Svetlana, Nordenström, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570065/ https://www.ncbi.nlm.nih.gov/pubmed/33239597 http://dx.doi.org/10.3390/ijns6030071

Ejemplares similares

Long-Term Outcomes of Congenital Adrenal Hyperplasia
por: Nordenström, Anna, et al.
Publicado: (2022)

The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients
por: Lajic, Svetlana, et al.
Publicado: (2020)

The impact of adherence and therapy regimens on quality of life in patients with congenital adrenal hyperplasia
por: Ekbom, Kerstin, et al.
Publicado: (2022)

Cognitive Function of Children and Adolescents With Congenital Adrenal Hyperplasia: Importance of Early Diagnosis
por: Messina, Valeria, et al.
Publicado: (2020)

Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self‐management
por: Ekbom, Kerstin, et al.
Publicado: (2021)

Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency
por: Gehrmann, Katharina, et al.
Publicado: (2019)

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022)

Good overall behavioural adjustment in children and adolescents with classic congenital adrenal hyperplasia
por: Messina, Valeria, et al.
Publicado: (2020)

Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2020)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Kocova, Mirjana, et al.
Publicado: (2020)

Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study
por: Falhammar, Henrik, et al.
Publicado: (2021)

Congenital adrenal hyperplasia in the Nordic countries – a potential base for long-term outcome studies
por: Nordenström, Anna, et al.
Publicado: (2023)

Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2021)

Very long‐chain acyl‐CoA dehydrogenase deficiency in a Swedish cohort: Clinical symptoms, newborn screening, enzyme activity, and genetics
por: Olsson, David, et al.
Publicado: (2022)

Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
por: Rangaswamaiah, Swetha, et al.
Publicado: (2020)

Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Lee, Peter A., et al.
Publicado: (2010)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019)

Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency
por: Al Alawi, Abdullah M., et al.
Publicado: (2019)

An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia
por: van’t Westeinde, Annelies, et al.
Publicado: (2023)

Neonatal Screening for Congenital Adrenal Hyperplasia in Indian Newborns with Reflex Genetic Analysis of 21-Hydroxylase Deficiency
por: Tippabathani, Jayakrishna, et al.
Publicado: (2023)

Increased Risk of Autoimmune Disorders in 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study
por: Falhammar, Henrik, et al.
Publicado: (2019)

Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia
por: Kolahdouz, Mahsa, et al.
Publicado: (2015)

Corrigendum: The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2020)

Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
por: Righi, Beatrice, et al.
Publicado: (2023)

Adrenocortical tumor in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Dung, Vu Chi, et al.
Publicado: (2015)

Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
por: Dörr, Helmuth G., et al.
Publicado: (2019)

Changes in resting-state functional connectivity in patients with congenital adrenal hyperplasia
por: Messina, Valeria, et al.
Publicado: (2022)

Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden
por: Sahlander, Fredrik, et al.
Publicado: (2022)

Ectopic Adrenal Tumor in a Patient With Untreated Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Alba, Eva L, et al.
Publicado: (2021)

Concurrence of Meningomyelocele and Salt-Wasting Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Kırmızıbekmez, Heves, et al.
Publicado: (2015)

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
por: Dörr, Helmuth G., et al.
Publicado: (2018)

Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency
por: Dörr, Helmuth G., et al.
Publicado: (2018)

Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Johannsen, T. H., et al.
Publicado: (2010)

Ethnic disparity in 21-hydroxylase gene mutations identified in Pakistani congenital adrenal hyperplasia patients
por: Khan, Aysha H, et al.
Publicado: (2011)

Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Subbarayan, Anbezhil, et al.
Publicado: (2014)

A Rare Combination: Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency and Turner Syndrome
por: Peltek Kendirci, Havva Nur, et al.
Publicado: (2012)

Long term follow up of growth in children with Congenital Adrenal Hyperplasia 21- Hydroxylase deficiency
por: Parikh, Ruchi, et al.
Publicado: (2015)

Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Choi, Jin-Ho, et al.
Publicado: (2016)

Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
por: Mnif, Mouna Feki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h968nmim9v4lbfqiq7nq5a23ec